25.01
25.01 (0%)
As of Apr 17, 2025
Harrow Health, Inc. [HROWL]
Source:
Company Overview
Harrow, Inc. is a leading eyecare pharmaceuticalcompany engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U.S. market.We help U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescriptionpharmaceutical products accessible and affordable to millions of Americans each year.
| Country | United States |
| Headquarters | nashville, tennessee |
| Phone Number | (615) 733-4730 |
| Industry | manufacturing |
| CEO | Imprimis Pharmaceuticals, Inc. |
| Website | www.harrow.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $199.6 |
| Operating Profit | $8.8 |
| Net Income | $-17.5 |
| Net Cash | $-26.8 |
Profit Ratios
| Gross Margin | $150.4 |
| Operating Margin | 4.4 |
| Profit as % of Revenues | -860.2% |
| Profit as % of Assets | -5% |
| Profit as % of Stockholder Equity | -25.2% |
Management Effectiveness
| Return on Equity | -25.2% |
| Return on Assets | -4.5% |
| Turnover Ratio | 56.9% |
| EBITA | $8.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $389 |
| Total Liabilities | $319.7 |
| Operating Cash Flow | $-22.2 |
| Investing Cash Flow | $-33.2 |
| Financing Cash Flow | $28.5 |
